Compounds
US8207176B2 · kind B2 · utility
0Cited by
96References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 24, 2006 |
| Grant date | Jun 26, 2012 |
| Priority date | — |
| Expiry date | Apr 20, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel substituted 2,4,8-trisubstituted 8H-pyrido[2,3-d]pyrimidin-7-one containing compounds, compositions, and use in therapy as CSBP/RK/p38 kinase inhibitors of Formulas (V) and (Va)wherein inter alia,
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.